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Introduction 
(–)-Spicigerolide (1) belongs to a family of polyacetate pyranone-containing natural products which 
exhibit a broad spectrum of pharmacological properties (Figure 1).1 These polyoxygenated 6-heptenyl-
5,6-dihydro-α-pyrones have been found in several species of the genus Hyptis and other related 
genera.2,3 In particular, spicigerolide has been isolated from Hyptis spicigera, a plant that is used in 
traditional Mexican medicine to treat gastrointestinal disturbances, skin infections, wounds and insects 
bites. The Michael acceptor moiety present in all these molecules potentially endows them with 
cytotoxic properties. Indeed, spicigerolide and some of its stereoisomers have shown cytotoxic activity 
in some cell tumoral lines.1,4 Due to their biological activity, several stereoselective approaches have 
already been applied to this group of polyoxygenated compounds. Thus, syntheses of (+)-anamarine 
(2),5 (–)-anamarine,6 and spicigerolide (1)1 have been described from carbohydrates. In contrast, the 
synthesis of (+)-hyptolide (3)7 is based on carbonyl additions, and there are alternate approaches to (+)-
anamarine (2) which exploit asymmetric dihydroxylation8 or aldol reactions.9  
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Figure 1 
As a part of our work on the stereocontrolled construction of sugar-type polyhydroxylated 
frameworks,10 we have explored a novel synthetic approach to these polyacetylated lactones. 
Specifically, we focused on the synthesis of the (–)-spicigerolide (1) as a representative example of this 
class of compounds. We envisaged that our recently reported methodology10a could be applied easily to 
the synthesis of 1. In contrast to the previous synthesis,1b,c our strategy creates the stereocentres 
independently rather than to rely on carbohydrates as chiral starting materials (Scheme 1). 
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Scheme 1 
 
Analysis of the structure of (–)-spicigerolide prompted us to consider that the pyranone could be 
obtained by selective olefin ring-closing metathesis (RCM) of the homoallyl acrylate 6, which in turn, 
could be prepared via asymmetric allylation of aldehyde 7 followed by acylation (Scheme 2). Regarding 
the remaining polyoxygenated chain, we tried to minimize the use of protecting groups by maintaining 
the oxygenated functional groups as acetates and using only silicon-derived protecting groups for 
transient protections. Thus, the α,β-unsaturated aldehyde 7 could arise from the related alkynol 8 
obtained by stereoselective alkynylation of aldehyde 9 with a protected 2-propyn-1-ol.  
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Scheme 2 
 
We considered that the key aldehyde 9 could be prepared from the protected (S)-lactaldehyde 10 and 
propargylic acetate 11 via our stereoselective approach to polyhydroxylated arrays.10a Therefore, we had 
to combine two stereoselective reactions: (i) Carreira’s asymmetric alkynylation of aldehydes11 with 
propargylic esters12 and (ii) stereoselective [3,3]-sigmatropic rearrangement of an allylic acetate 
(Scheme 3). Ozonolysis of the olefin moiety would afford aldehyde 9. 
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Results and Discussion 
As expected, (R)-1-phenylprop-2-ynyl acetate (R)-11 reacted with aldehyde 10 under Carreira’s 
conditions11 mediated by (–)-N-methylephedrine ((–)-NME) to afford anti,syn-12 in 95% yield as a 
single stereoisomer. The configuration of the alkyne 11 did not affect the diastereomeric ratio.13 
Analogously, the same Felkin-Anh type addition was observed when (S)-11 was used, leading to the 
single stereoisomer anti,anti-12 (Scheme 4). 
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Treatment of anti,syn-12 with LiAlH4 reduced the triple bond to an E-alkene with concomitant alcohol 
deprotection leading to a triol (13) which was acetylated in situ with acetic anhydride to form the 
triacetate 14 in 87% yield for the two steps (Scheme 5). Having achieved the right stereochemistry at C-
2 and C-3 in 14, we next attempted to transfer the chirality from C-6 to C-4 by a Pd-catalyzed [3,3]-
sigmatropic rearrangement.10a,14 Assuming a six-membered transition state having a chair conformation, 
we expected this reaction to be stereospecific, and therefore, that the configuration of C-6 in 14 would 
be conserved at C-4 in 15. Moreover, this rearrangement is an equilibrium that can be shifted sterically 
or electronically. In our case, we anticipated that formation of a double bond conjugated with a phenyl 
group would favour formation of the isomeric allylic triacetate 15. Indeed, when triacetate 14 was 
treated with 5% PdCl2(NCPh)2 in CH2Cl2 for 24 h, the rearranged product 15 was obtained as a major 
product in 70% yield (Scheme 5).  
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Scheme 5 
The key aldehyde 9 was obtained by ozonolysis followed by treatment with Me2S. This unstable 
aldehyde was immediately submitted to Carreira’s asymmetric alkynylation with 2-tert-
butyldiphenylsilyloxy-1-propyne (16) mediated by (+)-N-methylephedrine. Unfortunately, aldehyde 9 
did not react efficiently under the standard Carreira’s conditions; instead, three equivalents of alkyne 16, 
zinc triflate, (+)-NME and triethylamine were required to achieve good yields.15 Under these conditions, 
partial acetyl deprotection was observed. Therefore, the crude mixture was acetylated again to afford 
tetraacetate  8 in 71% yield (for three steps) and as a single diastereoisomer. Partial hydrogenation of the 
triple bond to the Z-olefin with Lindlar’s catalyst afforded allylic acetate 17 in 87% yield. Cleavage of 
the silicon-protecting group with TBAF caused the acetyl groups to migrate to the primary alcohol. 
Fortunately, deprotection with HF/pyridine furnished allylic alcohol 18 in 91% yield without any 
migration. 
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We then focused on assembling the pyranone ring. Swern oxidation of alcohol 18 afforded aldehyde 7 
(Scheme 7). Stereoselective allylation of 7 was initially attempted with (Ipc)2B-allyl without success.16 
However, Duthaler’s Ti-TADDOL mediated allylation17 with 19 provided the expected homoallylic 
alcohol 20 in good yield (84%) as a separable diastereomeric mixture (87:13). Acylation of alcohol 20 
with acryloyl chloride followed by RCM18 in the presence of the second-generation Grubbs’ ruthenium 
catalyst (21, 2% mol) afforded the (–)-spicigerolide (1), whose spectroscopic data was identical to that 
of the natural product.1 
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Conclusion 
We have reported an enantioselective synthesis of (–)-spicigerolide (1) which features independent 
stereocontrolled access to the different chiral centers. It constitutes the first application to natural 
product synthesis of our recently developed strategy for building polyhydroxylated chains, which is 
based on Pd(II) [3,3]-sigmatropic rearrangements and Carreira’s alkynylations. Furthermore, we were 
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able to shorten the sequence by minimizing the use of protecting groups.  
 
 
Experimental Section 
(1S,4R,5S)-5-tert-Butyldiphenylsilyloxy-4-hydroxy-1-phenylhex-2-ynyl acetate (anti,syn-12). 
Zn(OTf)2 (2.4 g, 6.6 mmol) was heated under vacuum in a flask. (–)-NME (1.3 g, 7.2 mmol) was added, 
and the flask was purged with nitrogen. Anhydrous toluene (10 mL) and Et3N (1.0 mL, 7.2 mmol) were 
added and the mixture was stirred at rt for 2 h 30 min. A solution of alkyne (R)-11 (1.04 g, 6.00 mmol) 
in toluene (5 mL) was added and stirred at rt for 30 min. Then, a solution of (S)-2-tert-
butyldiphenylsilyloxypropanal (10, 2.25 mg, 7.20 mmol) in toluene (5 mL) was added and the final 
mixture was stirred for 4 h (until TLC did not show significant changes). The reaction was quenched 
with saturated aqueous NH4Cl and CH2Cl2. The organic layer was washed with brine, dried over 
MgSO4, and evaporated under reduced pressure. The crude mixture was purified by flash 
chromatography with silica gel (hexane/AcOEt 70/30) to afford anti,syn-12 (2781 mg, 95%, >98% dr) 
as a colorless oil: Rf 0.30 (hexane/AcOEt 80/20); [α]D 25 –5.9 (c 0.95, CHCl3); IR (film) 3460, 2932, 
1742, 1457, 1369, 1227 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.70-7.65 (m, 4H), 7.55-7.49 (m, 2H), 
7.46-7.41 (m, 2H), 7.40-7.33 (m, 7H), 6.52 (d, J = 1.5 Hz, 1H), 4.32 (ddd, J = 1.6, 3.2, 6.9 Hz, 1H), 4.00 
(qd, J = 3.2, 6.3 Hz, 1H), 2.42 (d, J = 6.9 Hz, 1H), 2.08 (s, 3H), 1.12 (d, J = 6.3 Hz, 3H), 1.06 (s, 9H); 
13C NMR (100 MHz, CDCl3) δ 169.6, 136.8, 135.9, 135.7, 133.5, 133.4, 129.9, 129.8, 128.9, 128.6, 
127.8, 127.7, 127.6, 85.1, 82.6, 72.1, 67.3, 65.5, 26.9, 21.0, 19.3, 18.4; HMRS (ESI+) calcd for 
C30H34O4SiNa (M+Na)+ 509.2119, found 509.2120. 
 (1R,4R,5S,E)-1-Phenylhex-2-ene-1,4,5-triol (13). A solution of alkyne anti,syn-12 (2.92 g, 6.00 
mmol) in anhydrous THF (20 mL) was added dropwise at 0 ºC to a suspension of LiAlH4 (1.14 g, 30.0 
mmol), in anhydrous THF (50 mL) under N2. The mixture was stirred at rt for 15 h (until TLC did not 
show significant changes). The reaction was quenched with saturated potassium and sodium tartrate. 
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The aqueous layer was extracted with CH2Cl2. The combined organic layer was dried over MgSO4, and 
evaporated under reduced pressure. Triol 13 was obtained as a colorless oil and used as a crude mixture 
for the next transformation: Rf 0.31 (AcOEt); [α]D 25 +5.9 (c 0.58, CHCl3); IR (film) 3347, 2922, 1452, 
1366 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.36-7.28 (m, 5H), 5.97 (dd, J = 6.0, 15.3 Hz, 1H), 5.86 (dd, J 
= 6.0, 15.3 Hz, 1H), 5.23 (d, J = 6.0 Hz, 1H), 4.08 (dd, J = 3.3, 6.0 Hz, 1H), 3.87 (qd, J = 3.3, 6.3 Hz, 
1H), 2.90-2.40 (bs, 3H), 1.11 (d, J = 6.3 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 142.5, 128.6, 127.8, 
126.2, 135.6, 128.8, 75.5, 74.4, 70.2, 17.8; HMRS (ESI+) calcd for C12H16O3Na (M+Na)+ 231.0992, 
found 231.0899. 
(1R,4R,5S,E)-1-Phenylhex-2-ene-1,4,5-triyl triacetate (14). Anhydrous Et3N (5.02 mL, 36.0 mmol), 
Ac2O (2.84 mL, 30.0 mmol), DMAP (36 mg, 0.30 mmol) were added to a solution of triol 13 (6 mmol 
from anti,syn-12) in anhydrous CH2Cl2 (100 mL) under nitrogen atmosphere at rt. The mixture was 
stirred at rt until TLC showed no significant changes. The solvent was removed under reduce pressure 
and the mixture was purified by flash chromatography with silica gel (hexane/AcOEt 80/20) to give 14 
(1.662 g, 87% from anti,syn-12) as a colorless oil: Rf 0.69 (CH2Cl2); [α]D 25 –21.8 (c 1.05, CHCl3); IR 
(film) 2924, 1737, 1455, 1369, 1226 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.36-7.28 (m, 5H), 6.28 (d, J = 
6.0 Hz, 1H), 5.94 (ddd, J = 1.1, 6.0, 15.6 Hz, 1H), 5.68 (ddd, J = 1.3, 6.7, 15.6 Hz, 1H), 5.38 (ddt, J = 
1.0, 3.9, 6.7 Hz, 1H), 5.04 (qd, J = 3.9, 6.6 Hz, 1H), 2.10 (s, 3H), 2.08 (s, 3H), 1.97 (s, 3H), 1.17 (d, J = 
6.6 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 170.3, 169.9, 169.8, 138.6, 133.1, 128.6, 128.3, 127.1, 
126.6, 75.0, 74.4, 70.3, 21.2, 21.0, 21.0, 15.1; HMRS (ESI+) calcd for C18H22O6Na (M+Na)+ 357.1309, 
found 357.1299. 
 (2S,3S,4S,E)-6-Phenylhex-5-ene-2,3,4-triyl triacetate (15). PdCl2(NCPh)2 (95 mg, 0.25 mmol) was 
added to a solution of 14 (1.66 g, 4.97 mmol) in CH2Cl2 (30 mL) and stirred at rt for 24 h. The solvent 
was removed under reduced pressure and the crude mixture was purified by flash chromatography with 
silica gel (hexane/Et2O 70/30) to afford 15 (1.165 mg, 70%) as a colorless solid: Rf 0.41 (hexane/Et2O 
50/50); mp 68-70 ºC; [α]D 25 +21.2 (c 0.40, CHCl3); IR (film) 2925, 1740, 1457, 1370, 1218 cm-1; 1H 
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NMR (300 MHz, CDCl3) δ 7.38-7.25 (m, 5H), 6.69 (d, J = 15.8 Hz, 1H), 6.06 (dd, J = 7.3, 15.9 Hz, 
1H), 5.64 (ddd, J = 0.9, 5.7, 7.3 Hz, 1H), 5.30 (t, J = 5.8 Hz, 1H), 5.07 (m, 1H), 2.10 (s, 3H), 2.09 (s, 
3H), 2.02 (s, 3H), 1.24 (d, J = 6.5 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 170.3, 170.1, 169.9, 135.8, 
134.9, 128.6, 128.4, 126.7, 122.7, 74.1, 72.2, 67.9, 21.0, 21.0, 20.8, 15.4; HMRS (ESI+) calcd for 
C18H22O6Na (M+Na)+ 357.1309, found 357.1301. 
(2S,3S,4S,5S)-8-(tert-Butyldiphenylsilyloxy)oct-6-yne-2,3,4,5-tetrayl tetraacetate ( 8). A solution 
of 15 (167 mg, 0.500 mmol) in a mixture CH2Cl2/MeOH (4 mL/1 mL) was treated with O3 at -78 ºC 
until a blue color appeared. The flask was purged with N2 and Me2S (183 µL, 2.50 mmol) was added at 
–78 ºC. The reaction was stirred overnight at rt. The solvent was removed under reduced pressure and 
the residue was co-evaporated with toluene (4 x 30 mL) at 40 ºC. The aldehyde was obtained as a 
colorless oil and used as a crude mixture for the next transformation. Zn(OTf)2 (600 mg, 1.65 mmol) 
was activated by heating under vacuum. (+)-NME (323 mg, 1.80 mmol) was added, and the flask was 
purged with N2. Anhydrous toluene (2 mL) and Et3N (251 µL, 1.80 mmol) were added, and the mixture 
was vigorously stirred for 2 h. A solution of alkyne 16 (441 mg, 1.50 mmol) in toluene (0.7 mL) was 
added and stirred for 30 min, aldehyde 9 (0.5 mmol from 15) was added in solution in toluene (0.7 mL), 
and stirred for 2 h 30 min. The reaction was quenched with saturated aqueous NH4Cl. The organic layer 
was washed with brine, dried over MgSO4, and evaporated under reduced pressure. The crude mixture 
was treated with 4-DMAP (3.0 mg, 0.025 mmol), anhydrous Et3N (280 µL, 2.00 mmol) and Ac2O (142 
µL, 1.50 mmol) in anhydrous CH2Cl2 (10 mL) under N2. The reaction was stirred until TLC showed no 
significant change. The solvent was removed under reduced pressure. Purification by flash 
chromatography with silica gel (hexane/AcOEt 80/20) gave  8 (198 mg, 71% for 3 steps) as a colorless 
oil: Rf 0.23 (hexane/AcOEt 80/20); [α]D 25 +11.2 (c 0.80, CHCl3); IR (film) 2933, 1752, 1429, 1371 cm-1; 
1H NMR (400 MHz, CDCl3) δ 7.70-7.65 (m, 4H), 7.46-7.36 (m, 6H), 5.49 (dt, J = 1.6, 7.5 Hz, 1H), 5.45 
(dd, J = 2.7, 7.5 Hz, 1H), 5.29 (dd, J = 2.7, 8.0 Hz, 1H), 4.97 (dq, J = 6.4, 8.0 Hz, 1H), 4.30 (d, J = 1.6 
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Hz, 2H), 2.10 (s, 3H), 2.07 (s, 3H), 2.06 (s, 3H), 2.04 (s, 3H), 1.20 (d, J = 6.4 Hz, 3H), 1.04 (s, 9H); 13C 
NMR (100 MHz, CDCl3) δ 170.0, 170.0, 169.6, 169.3, 135.6, 132.8, 129.8, 127.7, 85.2, 78.6, 71.0, 69.6, 
67.1, 61.5, 52.5, 26.6, 21.0, 20.7, 20.7, 20.6, 19.1, 16.4; HMRS (ESI+) calcd for C32H40O928SiNa 
(M+Na)+ 619.2334, found 619.2308; HMRS (ESI+) calcd for C32H40O929SiNa (M+Na)+ 620.2329, found 
620.2342. 
(2S,3S,4S,5S,Z)-8-(tert-Butyldiphenylsilyloxy)oct-6-ene-2,3,4,5-tetrayl tetraacetate (17). 
Quinoline (3 µL) and Pd/CaCO3 poisoned with lead (Lindlar’s catalyst, 5 wt.%, 40 mg) were added to a 
solution of  8 (147 mg, 0.246 mmol) in AcOEt (8 mL). The mixture was shaken under hydrogen (1-2 
atmospheres) until TLC showed complete conversion. The suspension was filtered through a short pad 
of Celite®. The organic layer was washed with HCl 2 N (2 x 1 mL), brine, dried over MgSO4 and 
evaporated under reduced pressure. Purification by flash chromatography with silica gel (hexane/AcOEt 
90/10) gave 17 (129 mg, 87%) as a colorless oil: Rf 0.65 (hexane/AcOEt 70/30); [α]D 25 –37.8 (c 1.19, 
CHCl3); IR (film) 2935, 1750, 1429, 1370 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.71-7.66 (m, 4H), 7.45-
7.36 (m, 6H), 5.87 (dt, J = 6.0, 11.2 Hz, 1H), 5.41-5.28 (m, 3H), 5.23 (dd, J = 2.3, 8.4 Hz, 1H), 4.90 
(dq, J = 6.4, 8.4 Hz, 1H), 4.40 (ddd, J = 1.6, 6.0, 13.7 Hz, 1H), 4.33 (ddd, J = 1.6, 6.0, 13.7, 1H), 2.00 
(s, 3H), 1.98 (s, 3H), 1.98 (s, 3H), 1.91 (s, 3H), 1.16 (d, J = 6.4 Hz, 3H), 1.04 (s, 9H); 13C NMR (100 
MHz, CDCl3) δ 170.0, 170.0, 169.8, 169.4, 136.6, 135.6, 135.5, 133.5, 133.4, 129.7, 127.7, 124.1, 71.0, 
69.7, 67.0, 66.3, 60.2, 26.7, 21.0, 20.9, 20.6, 20.6, 19.1, 16.6; HMRS (ESI+) calcd for C32H42O928SiNa 
(M+Na)+ 621.2490, found 621.2485; HMRS (ESI+) calcd for C32H40O929SiNa (M+Na)+ 622.2486, 
found 622.2516. 
(2S,3S,4S,5S,Z)-8-Hydroxyoct-6-ene-2,3,4,5-tetrayl tetraacetate (18). Hydrogen fluoride pyridine 
(500 µL) was added to a solution of 17 (176 mg, 0.294 mmol) in anhydrous CH3CN (5 mL) and stirred 
until TLC showed complete conversion. The mixture was poured onto a solution of KF (10 mL), 
NaHCO3 (20 mL) and Et2O (30 mL). The aqueous layer was extracted with Et2O. The organic layer was 
dried over MgSO4 and evaporated under reduced pressure. Purification by flash chromatography with 
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silica gel (hexane/AcOEt 50/50) gave 18 (96 mg, 91%) as a colorless oil: Rf 0.08 (hexane/AcOEt 70/30); 
[α]D 25 –19.3 (c 0.650, CHCl3); IR (film) 3531, 2939, 1746, 1432, 1372 cm-1; 1H NMR (400 MHz, 
CDCl3) δ 5.94 (dt, J = 6.8, 11.1 Hz, 1H), 5.60 (dd, J = 7.8, 9.9 Hz, 1H), 5.45 (dd, J = 9.9, 11.1 Hz, 1H), 
5.38 (dd, J = 3.1, 7.7 Hz, 1H), 5.28 (dd, J = 3.1, 7.9 Hz, 1H), 4.95 (dq, J = 6.4, 7.8 Hz, 1H), 4.34 (m, 
1H), 4.15 (m, 1H), 2.36 (dd, J = 5.8, 6.9 Hz, 1H), 2.12 (s, 3H), 2.05 (s, 3H), 2.04 (s, 3H), 2.03 (s, 3H), 
1.21 (d, J = 6.4 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 170.4, 170.1, 170.1, 169.8, 135.8, 125.2, 71.2, 
69.7, 67.0, 66.8, 58.5, 21.0, 21.0, 20.7, 20.6, 16.2; HMRS (ESI+) calcd for C16H24O9Na (M+Na)+ 
383.1313, found 383.1305. 
(2S,3S,4S,5S,8R,Z)-8-Hydroxyundeca-6,10-diene-2,3,4,5-tetrayl tetraacetate (20). Oxalyl chloride 
(21 µL, 0.25 mmol) and DMSO (30 µL, 0.42 mmol) were stirred in anhydrous CH2Cl2 (2 mL) for 45 
min at –78 ºC. A solution of 18 (32.5 mg, 0.090 mmol) in CH2Cl2 (1 mL) was added and stirred for 30 
min at –78 ºC. Et3N (116 µL, 0.822 mmol) was added and stirred 15 min at –78 ºC then 20 min at rt. 
The mixture was poured onto Et2O (50 mL) and ammonium salts were filtered. The solvent was 
removed under reduced pressure and the residue was co-evaporated with toluene (4 x 20 mL) at 40 ºC. 
The aldehyde 7 was obtained as a colorless oil and used as a crude mixture for the next transformation. 
Allylmagnesium bromide (1M in Et2O, 117 µL, 0.117 mmol) and CpTiCl-(S,S)-TADDOL (19, 77 mg, 
0.13 mmol) in anhydrous Et2O (2 mL) were stirred for 1 h 30 at 0 ºC. A solution of aldehyde (0.090 
mmol from 18) in Et2O (1 mL) was added dropwise at –78 ºC and stirred for 1 h. The reaction was 
quenched with pH 7 buffer (1 mL) and stirred for 30 min. The aqueous layer was extracted with CH2Cl2. 
The organic layer was dried over MgSO4 and evaporated under reduced pressure. Purification by flash 
chromatography with silica gel (hexane/AcOEt 70/30) gave 20 (30.2 mg, 84%) and its minor 
diastereomer (4.5 mg, 12%) as colorless oils: Rf 0.25 (hexane/AcOEt 70/30); [α]D 25 –13.6 (c 1.06, 
CHCl3); IR (film) 3529, 2934, 1748, 1436, 1372 cm-1; 1H NMR (300 MHz, CDCl3) δ 5.87-5.66 (m, 3H), 
5.48 (m, 1H), 5.37 ( dd, J = 3.9, 6.4 Hz, 1H), 5.25 (dd, J = 3.9, 7.1 Hz, 1H), 5.17-5.07 (m, 2H), 4.96 (dq, 
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J = 6.4, 7.0 Hz, 1H), 4.54 (m, 1H), 2.66 (bs, 1H), 2.30 (m, 2H), 2.10 (s, 3H), 2.08 (s, 3H), 2.02 (s, 3H), 
2.02 (s, 3H), 1.22 (d, J = 6.4 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 170.4, 170.3, 169.9, 169.9, 139.1, 
133.8, 123.8, 118.1, 71.2, 69.9, 67.3, 67.2, 67.1, 41.4, 21.0, 20.9, 20.8, 20.7, 15.8; HMRS (ESI+) calcd 
for C19H28O9Na (M+Na)+ 423.1626, found 423.1623. 
(2S,3S,4S,5S,8R,Z)-8-(Acryloyloxy)undeca-6,10-diene-2,3,4,5-tetrayl tetraacetate (6). Anhydrous 
Et3N (30 µL, 0.21 mmol), acryloyl chloride (9 µL, 0.106 mmol) and 4-DMAP (0.3 mg, 0.003 mmol) 
were added to a solution of 20 (21.3 mg, 0.053 mmol) in anhydrous CH2Cl2 (1 mL) under N2. The 
reaction was stirred until TLC showed no significant change. The solvent was removed under reduced 
pressure. Purification by flash chromatography with silica gel (hexane/AcOEt 80/20) gave 6 (11.8 mg, 
50%) as a colorless oil: Rf 0.50 (hexane/AcOEt 70/30); [α]D 25 –37.0 (c 0.84, CHCl3); IR (film) 2925, 
1748, 1372 cm-1; 1H NMR (300 MHz, CDCl3) δ 6.38 (dd, J = 1.6, 17.3 Hz, 1H), 6.09 (dd, J = 10.4, 17.3 
Hz, 1H), 5.89 (m, 1H), 5.81 (dd, J = 1.6, 10.4 Hz, 1H), 5.78-5.58 (m, 3H), 5.45 (m, 1H), 5.36 (dd, J = 
2.3, 8.7 Hz, 1H), 5.28 (dd, J = 2.3, 8.6 Hz, 1H), 5.14-5.04 (m, 2H), 4.95 (dq, J = 6.3, 8.6 Hz, 1H), 2.43 
(m, 2H), 2.16 (s, 3H), 2.03 (s, 3H), 2.02 (s, 3H), 1.97 (s, 3H), 1.19 (d, J = 6.3 Hz, 3H); 13C NMR (75 
MHz, CDCl3) δ 170.3, 170.1, 170.0, 169.5, 164.8, 134.5, 132.8, 130.6, 128.7, 127.4, 118.2, 71.0, 69.6, 
69.2, 66.9, 66.6, 39.0, 21.1, 20.9, 20.7, 20.6, 16.6; HMRS (ESI+) calcd for C22H30O10Na (M+Na)+ 
477.1731, found 477.1719. 
(–)-Spicigerolide (1). A 0.01 M solution of 6 (10.8 mg, 0.025 mmol) in CH2Cl2 (2.5 mL) was refluxed 
in presence of benzylidene[1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidin-ylidene]dichloro(tricyclo-
hexylphosphine)ruthenium (21, Grubbs’ catalyst 2nd generation) (0.4 mg, 0.0005 mmol) for 2 h. The 
solvent was removed under reduced pressure. Purification by flash chromatography with silica gel 
(hexane/AcOEt 80/20) gave 1 (9.8 mg, 94%) as a colorless oil: Rf 0.11 (hexane/AcOEt 70/30); [α]D 25 –
23.0 (c 1.34, CHCl3); IR (film) 2925, 1735, 1457, 1372 cm-1; 1H NMR (400 MHz, CDCl3) δ 6.90 (ddd, J 
= 2.6, 5.8, 9.8 Hz, 1H), 6.05 (ddd, J = 0.9, 2.5, 9.8 Hz, 1H), 5.79 (dd, J = 9.3, 10.7 Hz, 1H), 5.51-5.29 
(m, 5H), 4.96 (dq, J = 6.3, 8.4 Hz, 1H), 2.51 (dddd, J = 0.9, 4.3, 5.8, 18.5 Hz, 1H), 2.35 (ddt, J = 2.5, 
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11.1, 18.5 Hz, 1H), 2.12 (s, 3H), 2.12 (s, 3H), 2.04 (s, 3H), 2.03 (s, 3H), 1.19 (d, J = 6.3 Hz, 3H); 13C 
NMR (100 MHz, CDCl3) δ 170.2, 170.1, 169.9, 169.9, 163.5, 144.8, 132.7, 128.6, 121.4, 73.7, 70.9, 
69.2, 66.9, 66.2, 29.2, 21.0, 20.9, 20.8, 20.7, 16.6; HMRS (ESI+) calcd for C20H26O10Na (M+Na)+ 
449.1418, found 449.1415. 
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